212 related articles for article (PubMed ID: 28619235)
1. Morphological and pharmacological determinants of peri-procedural myocardial infarction following elective stent implantation: Optical coherence tomography sub-analysis of the PRASFIT-Elective study.
Uzu K; Shinke T; Otake H; Takaya T; Osue T; Iwasaki M; Kinutani H; Konishi A; Kuroda M; Takahashi H; Terashita D; Hirata KI; Saito S; Nakamura M; Shite J; Akasaka T
J Cardiol; 2017 Dec; 70(6):545-552. PubMed ID: 28619235
[TBL] [Abstract][Full Text] [Related]
2. Lower on-treatment platelet reactivity during everolimus-eluting stent implantation contributes to the resolution of post-procedural intra-stent thrombus: serial OCT observation in the PRASFIT-Elective study.
Konishi A; Iwasaki M; Shinke T; Otake H; Nakagawa M; Hariki H; Osue T; Inoue T; Taniguchi Y; Nishio R; Kinutani H; Hiranuma N; Kuroda M; Hirata KI; Saito S; Nakamura M; Shite J; Akasaka T
Heart Vessels; 2018 Dec; 33(12):1423-1433. PubMed ID: 29967954
[TBL] [Abstract][Full Text] [Related]
3. Potent effect of prasugrel on acute phase resolution of intra-stent athero-thrombotic burden after percutaneous intervention to acute coronary syndrome.
Tsukiyama Y; Kozuki A; Shinke T; Otake H; Kijima Y; Masano T; Nagoshi R; Shibata H; Takeshige R; Yanaka KI; Shite J; Hirata KI
J Cardiol; 2018 Nov; 72(5):403-410. PubMed ID: 29731189
[TBL] [Abstract][Full Text] [Related]
4. Reduction of in-stent thrombus immediately after percutaneous coronary intervention by pretreatment with prasugrel compared with clopidogrel: An optical coherence tomography study.
Kubo T; Ino Y; Matsuo Y; Shiono Y; Kameyama T; Yamano T; Katayama Y; Taruya A; Nishiguchi T; Satogami K; Kashiyama K; Orii M; Kuroi A; Yamaguchi T; Tanaka A; Hozumi T; Akasaka T
J Cardiol; 2017 Feb; 69(2):436-441. PubMed ID: 27160709
[TBL] [Abstract][Full Text] [Related]
5. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ
Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034
[TBL] [Abstract][Full Text] [Related]
6. Impact of dual antiplatelet therapy with adjusted-dose prasugrel on mid-term vascular response in patients undergoing elective percutaneous coronary intervention with everolimus-eluting stents.
Toba T; Shinke T; Otake H; Sugizaki Y; Takeshige R; Onishi H; Nagasawa A; Tsukiyama Y; Yanaka K; Nagano Y; Yamamoto H; Kawamori H; Matsuura A; Ishihara T; Matsumoto D; Igarashi N; Hayashi T; Yasaka Y; Kadotani M; Fujii T; Shite J; Okada M; Sakakibara T; Hirata KI
Heart Vessels; 2019 Jun; 34(6):936-947. PubMed ID: 30599059
[TBL] [Abstract][Full Text] [Related]
7. Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.
van der Heijden DJ; Westendorp IC; Riezebos RK; Kiemeneij F; Slagboom T; van der Wieken LR; Laarman GJ
J Am Coll Cardiol; 2004 Jul; 44(1):20-4. PubMed ID: 15234399
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.
Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
Catheter Cardiovasc Interv; 2015 Mar; 85(4):564-72. PubMed ID: 25158217
[TBL] [Abstract][Full Text] [Related]
9. Assessment of echo-attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation.
Lee T; Kakuta T; Yonetsu T; Takahashi K; Yamamoto G; Iesaka Y; Fujiwara H; Isobe M
JACC Cardiovasc Interv; 2011 May; 4(5):483-91. PubMed ID: 21596319
[TBL] [Abstract][Full Text] [Related]
10. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
11. Association between changes in platelet reactivity during elective percutaneous coronary intervention and periprocedural myocardial infarction: A pilot study.
Kawai Y; Miyoshi T; Nakamura K; Shokoku G; Yamamoto K; Ono T; Tokioka K; Ohe T; Ito H
J Cardiol; 2019 Feb; 73(2):134-141. PubMed ID: 30201315
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase-1 activity affects the clopidogrel response in CYP2C19 loss-of-function carriers.
Nishio R; Shinke T; Otake H; Nakagawa M; Inoue T; Hariki H; Osue T; Taniguchi Y; Iwasaki M; Hiranuma N; Konishi A; Kinutani H; Kuroda M; Hirata K
Thromb Res; 2013 Nov; 132(5):558-64. PubMed ID: 24080149
[TBL] [Abstract][Full Text] [Related]
13. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM;
Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention.
Ang L; Thani KB; Ilapakurti M; Lee MS; Palakodeti V; Mahmud E
J Am Coll Cardiol; 2013 Jan; 61(1):23-34. PubMed ID: 23287370
[TBL] [Abstract][Full Text] [Related]
15. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
[TBL] [Abstract][Full Text] [Related]
16. Impact of oral P2Y12 inhibitors on residual thrombus burden and reperfusion indexes in patients with ST-segment elevation myocardial infarction.
Di Vito L; Versaci F; Limbruno U; Pawlowski T; Gatto L; Romagnoli E; Cattabiani MA; Micari A; Trivisonno A; Marco V; Prati F
J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):701-6. PubMed ID: 27467458
[TBL] [Abstract][Full Text] [Related]
17. Impact of plaque morphology on creatine kinase-MB elevation in patients with elective stent implantation.
Yonetsu T; Kakuta T; Lee T; Takahashi K; Yamamoto G; Iesaka Y; Fujiwara H; Isobe M
Int J Cardiol; 2011 Jan; 146(1):80-5. PubMed ID: 20591515
[TBL] [Abstract][Full Text] [Related]
18. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
[TBL] [Abstract][Full Text] [Related]
19. Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris.
Cuisset T; Hamilos M; Sarma J; Sarno G; Wyffels E; Vanderheyden M; Barbato E; Bartunek J; De Bruyne B; Wijns W
Am J Cardiol; 2008 Jun; 101(12):1700-3. PubMed ID: 18549843
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study.
Trenk D; Stone GW; Gawaz M; Kastrati A; Angiolillo DJ; Müller U; Richardt G; Jakubowski JA; Neumann FJ
J Am Coll Cardiol; 2012 Jun; 59(24):2159-64. PubMed ID: 22520250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]